Artificial neural network (ANN) and its variants are favored algorithm in designing cardiac arrhythmia classifier (CAC) for its high accuracy. However, the implementation of ultralow power ANN-CAC is challenging due to the intensive computations. Moreover, the imbalanced MIT-BIH database limits the ANN-CAC performance. Several novel techniques are proposed to address the challenges in the low power implementation. Firstly, continuous-in-time discrete-in-amplitude (CTDA) signal flow is adopted to reduce the multiplication operations. Secondly, conditional grouping scheme (CGS) in combination with biased training (BT) is proposed to handle the imbalanced training samples for better training convergency and evaluation accuracy. Thirdly, arithmetic unit sharing with customized high-performance multiplier improves the power efficiency. Verified in FPGA and synthesized in 0.18 μm CMOS process, the proposed CTDA ANN-CAC can classify an arrhythmia within 252 μs at 25 MHz clock frequency with average power of 13.34 μW for 75bpm heart rate. Evaluated on MIT-BIH database, it shows over 98% classification accuracy, 97% sensitivity, and 94% positive predictivity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/TBCAS.2019.2954479 | DOI Listing |
Ann Med
December 2025
Department of Clinical Pharmacology, Flinders Medical Centre, Southern Adelaide Local Health Network, Adelaide, Australia.
Background: Most older patients with atrial fibrillation (AF) have comorbidities. However, it is unclear whether specific comorbidity patterns are associated with adverse outcomes. We identified comorbidity patterns and their association with mortality in multimorbid older AF patients with different multidimensional frailty.
View Article and Find Full Text PDFActa Physiol (Oxf)
February 2025
Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
Aim: Long QT syndrome (LQTS) and catecholaminergic polymorphism ventricular tachycardia (CPVT) are inherited cardiac disorders often caused by mutations in ion channels. These arrhythmia syndromes have recently been associated with calmodulin (CaM) variants. Here, we investigate the impact of the arrhythmogenic variants D131E and Q135P on CaM's structure-function relationship.
View Article and Find Full Text PDFBiophys J
January 2025
Department of Pharmacology, University of California Davis, California 95616.
In every heartbeat, cardiac muscle cells perform excitation-Ca signaling-contraction (EC) coupling to pump blood against the vascular resistance. Cardiomyocytes can sense the mechanical load and activate mechano-chemo-transduction (MCT) mechanism, which provides feedback regulation of EC coupling. MCT feedback is important for the heart to upregulate contraction in response to increased load to maintain cardiac output.
View Article and Find Full Text PDFJ Coll Physicians Surg Pak
January 2025
Department of Emergency Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
The Valsalva manoeuvre is widely recognised for its effectiveness in reverting supra-ventricular tachycardia (SVT) in patients with good coordination. However, this is not applicable in sedated ventilated patients and there is a dearth of literature regarding the application of Valsalva in unconscious patients on mechanical ventilation. The authors, for the first time, present a novel non-pharmacological method to treat SVT in critically ill patients on mechanical ventilation, employing the high positive end-expiratory pressure (PEEP) technique.
View Article and Find Full Text PDFJ Coll Physicians Surg Pak
January 2025
Department of Cardiovascular Medicine, Second People's Hospital of Anhui Province, Hefei, China.
Objective: To explore the prognostic significance of Sestrin-2 and Galectin-3 levels in atrial fibrillation complicated by left atrial remodelling, aiming to offer novel insights for prevention, treatment, and follow-up strategies.
Study Design: Analytical study. Place and Duration of the Study: Department of Cardiology, Second People's Hospital of Anhui Province, Hefei, China, from January 2021 to December 2023.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!